Sullivan & Worcester has advised Maxim Group LLC and Curvature Securities, LLC. CleanCore Solutions, Inc. (NYSE: ZONE) has launched a $1.15 billion at-the-market facility for the...
CleanCore Solutions Launches $1.15 Billion At-the-Market Offering
Blackboxstocks Enters $5.8 Million At-the-Market Equity Agreement with Alexander Capital
Sullivan & Worcester has advised Alexander Capital LP. Blackboxstocks Inc. has entered into an at-the-market (ATM) equity offering agreement with Alexander Capital LP, with a maximum...
Channel Therapeutics Corporation’s Merger With Pelthos Therapeutics
Sullivan & Worcester advised Channel, Latham & Watkins advised Ligand, while Kelley Drye & Warren represented Murchinson on the deal. Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and...
Callan JMB’s $5.12 Million Initial Public Offering
Sichenzia Ross Ference Carmel represented Callan JMB Inc., while Sullivan & Worcester represented the underwriter in the offering. Callan JMB Inc. (NASDAQ: CJMB), an integrative logistics...
BranchOut Food’s $1.4 Million Follow-On Public Offering
Pachulski Stang Ziehl & Jones served as counsel to BranchOut, while Sullivan & Worcester served as counsel to the underwriters. BranchOut Food announced the closing of...
Chromocell Therapeutics Corporation’s $6.6 Million Initial Public Offering
Sullivan & Worcester represented Chromocell Therapeutics Corporation, while Manatt, Phelps & Phillips represented A.G.P./ Alliance Global Partners in the transaction. Chromocell Therapeutics Corporation executed their $6.6...